中文 | ENG

第52卷 第3期 2019-6
Gastric cancer and intrahepatic cholangiocarcinoma: Gastrectomy followed by left hepatectomy to achieve R0 resection

.........................

第52卷 第3期 2019-6
Long‑term survival of a patient with advanced hepatoid type adenocarcinoma of stomach and liver metastasis

.........................

第52卷 第3期 2019-6
Multiple massive intratumoral hemorrhages of metastatic brain melanoma after ventriculoperitoneal shunt

.........................

第52卷 第3期 2019-6
Using donor ascending aorta for venous reconstruction in a situs inversus heart transplantation

.........................

第52卷 第3期 2019-6
Obstructive tracheal neoplasm: Imaging and therapeutical features of pleomorphic adenoma

.........................

第52卷 第3期 2019-6
Enhancing rat full-thickness skin wounds with a mixed aloe/chitosan gel

.........................

第52卷 第3期 2019-6
Evaluation of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy

.........................

第52卷 第3期 2019-6
Long-term surgical outcome of median nerve injuries

.........................

第52卷 第2期 2019-4
Occult medullary breast carcinoma in a male

.........................

第52卷 第2期 2019-4
Innovative methods of maintaining operation records using the online Google spreadsheet

.........................

第52卷 第2期 2019-4
Closing of postoperative integument, skull bones and dura defects

.........................

第52卷 第2期 2019-4
Periorbital purulent drainage of resulting from bacterial pansinusitis

.........................

第52卷 第2期 2019-4
A simple technique to create spur in loop colostomy

.........................

第52卷 第2期 2019-4
A randomized clinical trial comparing a collagen-based composite dressing versus topical antibiotic ointment on healing full-thickness skin wounds to promote epithelialization

.........................

第52卷 第2期 2019-4
Biodegradation patterns of injected composite bone cements in porcine vertebral bodies: A study using quantitative computed tomography

.........................

第52卷 第2期 2019-4
Geriatric trauma: A population‑based study

.........................

第52卷 第1期 2019-2
Low‑tidal‑volume ventilation for recipients of lung transplant: Ready for clinical use?

.........................

第52卷 第1期 2019-2
Primary small gut lymphoma presenting as an incarcerated inguinal hernia in an adult

.........................

第52卷 第1期 2019-2
Metastatic lung neuroendocrine carcinoma presenting as a breast lump

.........................

第52卷 第1期 2019-2
Neglected giant dermatofibrosarcoma protuberans

.........................
登入帳號才能閱讀全文
 
篇名 Lessening hepatic injury in cholestatic liver by optimal dietary docosahexaenoic acid supplementation in rats
作者 Guan‑Yeu Diau, Shih‑Ming Kuo, Chieh‑Wen Lin
卷期/出版年月 51卷3期 (2018/6)
頁次 91-97
摘要 Background: Dietary adjuvant management for the cholestatic liver disease before/after surgery is an important clinical issue. This study investigated the possibility for the dietary supplementation of docosahexaenoic acid (DHA) to treat cholestasis liver through the bile duct ligation (BDL) rat model. Materials and Methods: Thirty‑six male Wistar rats were divided into four groups (N: no BDL; BL, 1P, 5P: received BDL) and consumed either a regular diet (N, BL) or of DHA‑enriched diet (1P: at 1% and 5P: at 5% weight percentage) for 4 weeks. The liver fatty acids (FAs) profiles, serum aspartate transaminase (AST), alanine aminotransferase (ALT), total bilirubin, alkaline phosphatase, interleukin‑2 (IL‑2), interferon γ (INF‑γ), and pathological examination with H and E, Masson, CD56 (natural killer cell), CD68 (macrophage) were examined. Results: The DHA dietary supplement increased liver DHA after BDL. Liver DHA N 8.09 ± 0.60% and BL 8.41 ± 0.55% were the lowest than the supplemented groups 1P 12.57 ± 1.16%, 5P 18.36 ± 2.00% (P = 0.000). However, liver arachidonic acid (20:4n‑6) 1P 23.13 ± 2.19% was the highest than N 18.86 ± 4.31%, BL 17.13 ± 3.07%, 5P 18.78 ± 1.76% (P = 0.001). The serum AST (U/L) in N 147.4 ± 28.2 and 1P 155.9 ± 35.1 were lower than B 317.1 ± 195.8, 5P 326.9 ± 141. 8 (P = 0.006). The serum alkaline phosphatase (U/L) showed the same trend N 49.8 ± 5.4, 1P 67.6 ± 21.1 were lower than the BL 172.2 ± 108.1, 5P 171.1 ± 149.1 (P = 0.017). Pathological examination with H and E, Masson revealed the fibrosis was prominent in BL, 5P. However, there were no significant differences in serum ALT, total bilirubin, IL‑2, INF‑γ, and immunohistochemical stain for the CD56, CD68. Conclusions: The results suggested that optimal dietary supplementing of DHA (1P) had less destruction and liver enzymes released after the BDL. However, higher enriched DHA (5P) could not benefit from this dietary treatment. The body weight did not increase even with this enriched high FAs diet after BDL for 4 weeks.
關鍵詞 Bile duct ligation, cholestasis liver disease, docosahexaenoic acid, hepatic injury
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@24drs.com